Lotrafilcon B contact lenses
DeviceOther names: AIR OPTIX® AQUA
NCT Number: NCT02495948
The purpose of this study is to evaluate cholesterol sorption by AIR OPTIX® AQUA lenses compared to ULTRA lenses after 30 days of wear.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: AIR OPTIX® AQUA
Other names: Bausch + Lomb ULTRA
Used as a cleaning, disinfection, and storage solution for silicone hydrogel and soft contact lenses
Other names: CLEAR CARE®
Used for rinsing contact lenses, as needed
Other names: SENSITIVE EYES® PLUS
Time frame: Day 30, each product
The contact lens (right eye) was removed and stored dry and frozen until analysis. Total cholesterol deposits (cholesterol and cholesterol esters) were extracted from the lens and measured in micrograms. Lower deposits indicate increased lens performance. Study originally intended to analyze 36 lenses per arm, but actual number of lenses analyzed was less due to measurement error.
Alcon Research
Industry
One Month Clinical Comparison of Lotrafilcon B and Samfilcon A
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04075591
Eye Diseases, Refractive Error
Los Angeles, California, United States
View Trial DetailsNCT07168564
Ametropia, Eye Diseases
Bloomington, Indiana, United States
View Trial DetailsNCT05656027
Eye Diseases, Myopia
Chandler, Arizona, United States
View Trial DetailsNCT05753189
Eye Diseases, Myopia
Dothan, Alabama, United States
View Trial Details